At a glance
- Originator Yamanouchi
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Cancer in Japan (Unknown route)